• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用书面行动计划改善化脓性汗腺炎患者教育:一项随机对照试验

Improving hidradenitis suppurativa patient education using written action plan: a randomized controlled trial.

作者信息

Thompson Alyssa M, Fernandez Jennifer M, Shih Terri, Hamzavi Iltefat, Hsiao Jennifer L, Shi Vivian Y

机构信息

College of Medicine, University of Arizona, Tucson, AZ, USA.

David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

出版信息

J Dermatolog Treat. 2022 Aug;33(5):2677-2679. doi: 10.1080/09546634.2021.1970707. Epub 2021 Sep 27.

DOI:10.1080/09546634.2021.1970707
PMID:34579620
Abstract

The waxing-and-waning nature of hidradenitis suppurativa (HS), complex treatment plans, along with variable responsiveness to therapy, can create management challenges for patients. In this pilot cross-over randomized controlled trial, we aim to evaluate the effectiveness a HS-written action plan (HSWAP) on patient disease understanding and confidence in recognizing flares and adjusting management. Participants were randomized into a pre-crossover control group that received a verbal consultation (VC)-only, and an intervention group which received the VC + HSWAP. The pre-crossover control group then crossed over (post-crossover control) to also receive the VC + HSWAP (ClinicalTrials.gov Identifier: NCT04600375). Patient comprehension of their disease and management steps was high after both a thorough VC and HSWAPs. However, the majority of patients prefer receiving both a VC and a HSWAP. After the addition of the HSWAP, pre-crossover control group patients' understanding and confidence of their disease and management plan increased across all surveyed questions.

摘要

化脓性汗腺炎(HS)病情的反复无常、复杂的治疗方案以及对治疗的不同反应,会给患者的管理带来挑战。在这项试点交叉随机对照试验中,我们旨在评估一份HS书面行动计划(HSWAP)对患者疾病理解以及识别病情发作和调整管理的信心的有效性。参与者被随机分为交叉前仅接受口头咨询(VC)的对照组和接受VC + HSWAP的干预组。交叉前对照组随后交叉(交叉后对照组)也接受VC + HSWAP(ClinicalTrials.gov标识符:NCT04600375)。经过全面的VC和HSWAP后,患者对其疾病和管理步骤的理解程度很高。然而,大多数患者更喜欢同时接受VC和HSWAP。在添加HSWAP后,交叉前对照组患者在所有调查问题上对其疾病和管理计划的理解和信心都有所提高。

相似文献

1
Improving hidradenitis suppurativa patient education using written action plan: a randomized controlled trial.使用书面行动计划改善化脓性汗腺炎患者教育:一项随机对照试验
J Dermatolog Treat. 2022 Aug;33(5):2677-2679. doi: 10.1080/09546634.2021.1970707. Epub 2021 Sep 27.
2
Improving health literacy and treatment understanding of hidradenitis suppurativa using group educational interventions.使用团体教育干预提高化脓性汗腺炎的健康素养和治疗理解。
J Dermatolog Treat. 2019 Nov;30(7):708-713. doi: 10.1080/09546634.2018.1562536. Epub 2019 Jun 24.
3
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.比美吉珠单抗治疗中重度化脓性汗腺炎的疗效和安全性:一项 2 期、双盲、安慰剂对照随机临床试验。
JAMA Dermatol. 2021 Nov 1;157(11):1279-1288. doi: 10.1001/jamadermatol.2021.2905.
4
[Intense pulsed light treatment for hidradenitis suppurativa: a within-person randomized controlled trial].[强脉冲光治疗化脓性汗腺炎:一项自身随机对照试验]
Eur J Dermatol. 2020 Dec 1;30(6):723-729. doi: 10.1684/ejd.2020.3920.
5
Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial.阿达木单抗联合手术治疗中重度化脓性汗腺炎的疗效和安全性:SHARPS 随机临床试验。
JAMA Surg. 2021 Nov 1;156(11):1001-1009. doi: 10.1001/jamasurg.2021.3655.
6
Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.法国 ComPaRe 国家电子队列研究中化脓性汗腺炎的基线特征,并与其他大型化脓性汗腺炎队列进行比较。
Dermatology. 2021;237(5):748-758. doi: 10.1159/000513447. Epub 2021 Jan 27.
7
Hidradenitis suppurativa: surgical and other management techniques.化脓性汗腺炎:手术及其他治疗方法。
Dermatol Surg. 2012 Apr;38(4):517-36. doi: 10.1111/j.1524-4725.2011.02186.x. Epub 2011 Oct 14.
8
Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019.第四届化脓性汗腺炎进展研讨会报告 2019 年。
J Am Acad Dermatol. 2021 Jan;84(1):120-129. doi: 10.1016/j.jaad.2020.05.114. Epub 2020 Jun 1.
9
Management of adolescents with hidradenitis suppurativa.化脓性汗腺炎青少年患者的管理。
J Dermatolog Treat. 2021 Dec;32(8):1035-1038. doi: 10.1080/09546634.2020.1716933. Epub 2020 Jan 23.
10
Randomized Controlled Trials for the Treatment of Hidradenitis Suppurativa.治疗化脓性汗腺炎的随机对照试验
Dermatol Clin. 2016 Jan;34(1):69-80. doi: 10.1016/j.det.2015.08.012.

引用本文的文献

1
Response to "Hidradenitis suppurativa electronic medical record (EPIC) tool: A convenient tool of hidradenitis suppurativa specialty clinics".对“化脓性汗腺炎电子病历(EPIC)工具:化脓性汗腺炎专科诊所的便捷工具”的回应
JAAD Int. 2025 Jan 21;19:65-66. doi: 10.1016/j.jdin.2025.01.003. eCollection 2025 Apr.
2
Expert Practices in Hidradenitis Suppurativa Flare Management: A Cross-Sectional Survey Study.化脓性汗腺炎发作管理的专家实践:一项横断面调查研究。
Skin Appendage Disord. 2024 Jun;10(3):224-228. doi: 10.1159/000536094. Epub 2024 Jan 24.
3
No-shows to hidradenitis suppurativa clinic visits: Patient perspectives.
化脓性汗腺炎门诊预约爽约:患者视角
Skin Health Dis. 2023 Dec 10;4(2):e322. doi: 10.1002/ski2.322. eCollection 2024 Apr.
4
A practical guide to starting a hidradenitis suppurativa specialty clinic.开设化脓性汗腺炎专科诊所实用指南。
JAAD Int. 2023 Feb 15;11:117-120. doi: 10.1016/j.jdin.2023.01.021. eCollection 2023 Jun.
5
Low Rates of Psychosocial Screening and Lifestyle Counseling in Hidradenitis Suppurativa Patients in the USA.美国化脓性汗腺炎患者心理社会筛查和生活方式咨询的低比率
Skin Appendage Disord. 2023 Mar;9(2):94-98. doi: 10.1159/000528253. Epub 2023 Jan 5.